Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Growth Model Portfolio Rebalancing EXIT (NYSE: IMAX) and ENTRY (NASDAQ: ILMN)

Dec 20, 2024 | Team Kalkine
Growth Model Portfolio Rebalancing EXIT (NYSE: IMAX) and ENTRY (NASDAQ: ILMN)
Image source: shutterstock

  • IMAX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (US$)
  • ILMN:NASDAQ
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

1. Exit Case: Imax Corporation (NYSE: IMAX)

Overview: Imax Corporation (NYSE: IMAX) is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium, architecture, patented intellectual property, and specialized equipment, the Company offers an end-to-end solution to create content experiences. The Company operates through two segments: Content Solutions and Technology Products and Services.

IMAX has been a part of the ‘Growth Model Portolio’ since 30 September 2024, however, considering the recent rally, trading near the resistance in the stock, support & resistance levels, and ~21.63% upside from the entry price, an ‘Exit’ is recommended from the stock near the resistance of USD 24.85, as on (19th December 2024).

Imax Corporation (NYSE: IMAX) part of Kalkine’s US Growth Model Portfolio, has reached near its resistance level around which an exit case emerges.

1.1 Support and Resistance Summary as provided in our last published report dated 30th September 2024.

1.2 Imax Corporation (NYSE: IMAX)

2. New Entry Case: Illumina Inc (NASDAQ: ILMN)

Overview: Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Technical Analysis: The Relative Strength Index (RSI) over a 14-day period stands at a value of 37.73, downward trending, with expectations of a consolidation or an upward momentum once USD 120-USD 130 support hold. Additionally, the stock's current positioning is between both the 50-period SMA and 200-period SMA, which may serve as dynamic short to medium-term resistance and support levels respectively.

Considering the above mentioned factors, technical analysis, support & resistance levels, key risks and outlook an ‘Entry’ is recommended in the ‘Growth Model Portfolio’ at the closing market price of USD 134.00, as on 19th December 2024.

2.1 Support and Resistance Summary as on 19th December 2024

2.2 One Year Technical Price Chart (NASDAQ: ILMN)

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency as of (19thDecember 2024). The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings.

Disclaimer

This information should not be relied upon as personal financial advice by Kalkine on (i) the stocks or (ii) the use or suitability of the model portfolios. Only an investor knows about their circumstances to make an investment decision.

Model Portfolio has been prepared for illustrative purpose only and does not consider the objectives, financial situation or needs of any investor. Accordingly, investors should, before acting on the information, consider its appropriateness, having regard to their objectives, financial situation and needs. Past performance is not necessarily indicative of future performance results. Actual investment returns will vary, and the value of investments can go up or down.


Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Copyright © 2024 Krish Capital Pty Ltd. All rights reserved.

Past performance is not a reliable indicator of future performance.